STOCK TITAN

Universal Technical (NYSE: UTI) legal chief sells 23,654 shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Universal Technical Institute executive Christopher E. Kevane reported an open-market sale of company stock. On March 27, 2026, the EVP and Chief Legal Officer sold 23,654 shares of common stock at a weighted average price of $37.5461 per share. After this transaction, he directly holds 83,521 shares of Universal Technical Institute common stock.

Positive

  • None.

Negative

  • None.

Insights

EVP and Chief Legal Officer executed a modest open-market stock sale while retaining a sizeable stake.

Christopher E. Kevane, EVP and Chief Legal Officer of Universal Technical Institute, carried out an open-market sale of 23,654 common shares at a weighted average price of $37.5461 on March 27, 2026. The filing describes this as a standard open-market transaction.

Following the sale, Kevane still directly owns 83,521 shares, indicating he maintains a meaningful ongoing equity position. The transaction involves only non-derivative common stock, with no remaining derivative positions listed in this filing, and appears as a routine insider sale rather than a transformational event.

Insider Kevane Christopher E.
Role EVP and Chief Legal Officer
Sold 23,654 shs ($888K)
Type Security Shares Price Value
Sale Common Stock, $0.0001 par value 23,654 $37.5461 $888K
Holdings After Transaction: Common Stock, $0.0001 par value — 83,521 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares sold 23,654 shares Open-market sale on March 27, 2026
Weighted average sale price $37.5461 per share Common stock transaction
Shares owned after transaction 83,521 shares Direct holdings following sale
Net share direction 23,654 net shares sold Form 4 transaction summary
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
non-derivative financial
""transaction_type": "non-derivative""
Common Stock, $0.0001 par value financial
""security_title": "Common Stock, $0.0001 par value""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kevane Christopher E.

(Last)(First)(Middle)
4225 E. WINDROSE DRIVE, SUITE 200

(Street)
PHOENIX ARIZONA 85032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL TECHNICAL INSTITUTE INC [ UTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.0001 par value03/27/2026S23,654D$37.5461(1)83,521D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $37.16 to $37.79. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
/s/ Christopher Kevane03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did UTI executive Christopher Kevane do in this Form 4 filing?

Christopher E. Kevane, EVP and Chief Legal Officer at Universal Technical Institute (UTI), reported an open-market sale of 23,654 shares of common stock. The sale was executed at a weighted average price of $37.5461 per share on March 27, 2026, and was directly owned.

How many UTI shares did Christopher Kevane sell and at what price?

Kevane sold 23,654 shares of Universal Technical Institute (UTI) common stock in an open-market transaction. The shares were sold at a weighted average price of $37.5461 per share, reflecting multiple trades within a price range disclosed in the accompanying footnote.

How many UTI shares does Christopher Kevane still own after this sale?

After the reported sale, Kevane directly holds 83,521 shares of Universal Technical Institute (UTI) common stock. This remaining position, reported in the Form 4, shows he retains a significant personal equity stake in the company following the single open-market transaction.

Was Christopher Kevane’s UTI stock transaction an open-market sale?

Yes. The Form 4 identifies the transaction as an open-market sale of Universal Technical Institute (UTI) common stock. The sale used transaction code “S,” and the filing’s normalized fields describe it as an open-market sale of 23,654 non-derivative shares at a weighted average price.

Does the UTI Form 4 show any option exercises or derivative transactions?

No. The Form 4 for Universal Technical Institute (UTI) reports only a non-derivative common stock sale by Christopher Kevane. The derivative summary section is empty, indicating there were no option exercises, conversions, or other derivative security transactions disclosed in this particular filing.

What does the weighted average sale price mean in this UTI insider trade?

The weighted average price of $37.5461 means Kevane’s 23,654 UTI shares were sold through multiple trades at different prices. The filing notes trades occurred between $37.16 and $37.79 per share, and the average reflects the combined value across those individual executions.